Recombinant multi-species Mouse/SMN2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Mouse/SMN2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is part of a 500 kb inverted duplication on chromosome 5q13. This duplicated region contains at least four genes and repetitive elements which make it prone to rearrangements and deletions. The repetitiveness and complexity of the sequence have also caused difficulty in determining the organization of this genomic region. The telomeric and centromeric copies of this gene are nearly identical and encode the same protein. While mutations in the telomeric copy are associated with spinal muscular atrophy, mutations in this gene, the centromeric copy, do not lead to disease. This gene may be a modifier of disease caused by mutation in the telomeric copy. The critical sequence difference between the two genes is a single nucleotide in exon 7, which is thought to be an exon splice enhancer. Note that the nine exons of both the telomeric and centromeric copies are designated historically as exon 1, 2a, 2b, and 3-8. It is thought that gene conversion events may involve the two genes, leading to varying copy numbers of each gene. The full length protein encoded by this gene localizes to both the cytoplasm and the nucleus. Within the nucleus, the protein localizes to subnuclear bodies called gems which are found near coiled bodies containing high concentrations of small ribonucleoproteins (snRNPs). This protein forms heteromeric complexes with proteins such as SIP1 and GEMIN4, and also interacts with several proteins known to be involved in the biogenesis of snRNPs, such as hnRNP U protein and the small nucleolar RNA binding protein. Four transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Sep 2008]
The Alternative Names of target: BCD541,C-BCD541,Component of gems 1,GEMIN1,Gemin-1,Mouse,SMN,SMN1,SMN2,SMNC,Survival motor neuron protein,TDRD16B

Target products collectionGo to Mouse/SMN2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP11496-Ag-1/ GM-Tg-hg-IP11496-Ag-2 Human Mouse/SMN2 protein Human
GM-Tg-rg-IP11496-Ag-1/ GM-Tg-rg-IP11496-Ag-2 Rat Mouse/SMN2 protein Rat
GM-Tg-mg-IP11496-Ag-1/ GM-Tg-mg-IP11496-Ag-2 Mouse Mouse/SMN2 protein Mouse
GM-Tg-cynog-IP11496-Ag-1/ GM-Tg-cynog-IP11496-Ag-2 Cynomolgus/Rhesus macaque Mouse/SMN2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP11496-Ag-1/ GM-Tg-felg-IP11496-Ag-2 Feline Mouse/SMN2 protein Feline
GM-Tg-cang-IP11496-Ag-1/ GM-Tg-cang-IP11496-Ag-2 Canine Mouse/SMN2 protein Canine
GM-Tg-bovg-IP11496-Ag-1/ GM-Tg-bovg-IP11496-Ag-2 Bovine Mouse/SMN2 protein Bovine
GM-Tg-equg-IP11496-Ag-1/ GM-Tg-equg-IP11496-Ag-2 Equine Mouse/SMN2 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP11496-Ag-1/ GM-Tg-hg-IP11496-Ag-2; GM-Tg-rg-IP11496-Ag-1/ GM-Tg-rg-IP11496-Ag-2;
GM-Tg-mg-IP11496-Ag-1/ GM-Tg-mg-IP11496-Ag-2; GM-Tg-cynog-IP11496-Ag-1/ GM-Tg-cynog-IP11496-Ag-2;
GM-Tg-felg-IP11496-Ag-1/ GM-Tg-felg-IP11496-Ag-2; GM-Tg-cang-IP11496-Ag-1/ GM-Tg-cang-IP11496-Ag-2;
GM-Tg-bovg-IP11496-Ag-1/ GM-Tg-bovg-IP11496-Ag-2; GM-Tg-equg-IP11496-Ag-1/ GM-Tg-equg-IP11496-Ag-2
Products Name Mouse/SMN2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name Mouse/SMN2
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Mouse/SMN2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.